See all
|
Article Summary
|
|
|
AVI BioPharma, Inc., a developer of RNA–based drugs, announced the signing of an exclusive worldwide license agreement with the University of Western Australia (UWA) to a patent application related to the treatment of Duchenne Muscular Dystrophy (DMD).
--- M&A/PARTNERSHIPS TOP ARTICLES ---
Receive free subspecialty "5-minute updates" via email
|
 |
 |
Read a Different Specialty |
|
|
|
|
 |
Profession Index
|
|
|
|
|
 |
|
|